The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

The US Food and Drug Administration (FDA) will see the biggest cuts, with 19% of jobs in the agency being eliminated.

Soleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...

Ionis has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise olezarsen.

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...